Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gynecologic 2Genitourinary 2Gastrointestinal 2

Conditions

Melanoma 65Kidney Neoplasms 24Carcinoma, Renal Cell 23Neoplasm Metastasis 20Breast Neoplasms 16Skin Neoplasms 14Ovarian Neoplasms 11Pancreatic Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Neoplasms 7Uterine Cervical Neoplasms 6Neuroblastoma 6Lymphoma 6Leukemia, Myeloid, Acute 6Leukemia 6Colorectal Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Lung Neoplasms 5Colonic Neoplasms 5Urogenital Neoplasms 4Leukemia, Lymphocytic, Chronic, B-Cell 4Carcinoma, Ovarian Epithelial 4Burkitt Lymphoma 4Sezary Syndrome 3Rectal Neoplasms 3Mycosis Fungoides 3

Interventions

Radiotherapy 4Cisplatin 4Radiation 33-aminopyridine-2-carboxaldehyde thiosemicarbazone 3fludarabine phosphate 2fludarabine 2entinostat 2aldesleukin 2Trastuzumab 2Platinum 2Cyclophosphamide 2Congresses as Topic 2Brachytherapy 21,2-diaminocyclohexaneplatinum II citrate 2tipifarnib 1bintrafusp alfa protein, human 1adavosertib 1Watchful Waiting 1Therapeutics 1Ritonavir 1Radiotherapy, Intensity-Modulated 1Psychiatric Rehabilitation 1Paclitaxel 1Observation 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Interleukin-2 1Interleukin-12 Subunit p35 1Interleukin-12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Vaginal Neoplasms × aldesleukin × Clear all
NCT01585428 2018-03-07

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
29 enrolled 12 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Papillomavirus Infections

NCT02280811 2017-09-06

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
12 enrolled 19 charts
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡